Caitong International Asset Management’s Achieve Life Sciences ACHV Stock Holding History

Caitong International Asset Management’s Portfolio ACHV Stock Details ACHV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6	Buy	+2	New	+$9	﹤0.01%	2216

Other funds holding ACHV

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Caitong International Asset Management's ACHV Position: Q1 2026 in Review

Caitong International Asset Management opened a new position in Achieve Life Sciences (ACHV) in Q1 2026: 2 shares worth $6. The stake represents ﹤0.01% of the portfolio and ranks #2216 among its holdings.

81 funds tracked by Wall St. Rank hold ACHV as of Q1 2026.

Caitong International Asset Management held 2 shares of Achieve Life Sciences worth $6 as of Q1 2026.
Achieve Life Sciences was a new Caitong International Asset Management position in Q1 2026.
Achieve Life Sciences made up ﹤0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #2216 holding.
81 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.